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Summary 
Knowing the three-dimensional structure of a protein may be useful in understanding its function. 
In this study, induced mutagenesis protein B (ImuB) from Mycobacterium tuberculosis was 
analyzed using molecular biology and molecular modelling techniques. The Rv3394c gene 
expressing ImuB was obtained from the group of Prof. Digby Warner at the Institute of Infectious 
Diseases and Molecular Medicine, University of Cape Town. Rv33974c was amplified from an 
expression plasmid using polymerase chain reaction (PCR) and inserted into multiple expression 
vectors. The pMal-c2X-Rv3394c construct was most successful in producing ImuB as a fusion 
protein with N-terminal maltose binding protein in an E. coli expression systems. Attempts were 
undertaken to refold insoluble ImuB. Soluble MBP-ImuB was purified by affinity chromatography 
and size-exclusion chromatography. Purified MBP-ImuB was concentrated and used for hanging 
drop crystallization experiments. Crystallization of ImuB remained elusive as protein crystals did 
not form. A homology model of ImuB was generated based on structurally related Y-family DNA 
polymerases. ImuB, however, lacks the catalytic residues required for DNA replication. Sequence 
analysis an identified a potentially disordered C-terminal domain. Together, this would suggest 
that ImuB is not directly responsible for induced mutagenesis but is required as an accessory 
protein for induced mutagenesis to occur.   
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1. Introduction 
1.1.  Mycobacterium tuberculosis and tuberculosis 
1.1.1. Tuberculosis epidemiology 
Tuberculosis (TB) is a contagious human disease ranked as one of the most lethal infections 
alongside HIV/AIDS and malaria (Bloom and Fine, 1994). TB was declared a global health 
emergency by the World health Organization (WHO) in 1993 and is responsible for the death of 
~2 million lives annually (Chen et al., 2009). Mycobacterium tuberculosis (Mtb) is the causative 
agent of TB and is spread via aerosols from an active TB host through contact with infected bodily 
fluid (Wheeler and Ratledge, 1994; Warner and Mizrahi, 2006). Mtb typically infects the lungs of 
the human host causing pulmonary TB but is known to infect other body parts causing extra-
pulmonary TB (Katz et al., 2007; Chen et al., 2009). During infection, Mtb bacilli permeate and 
enter the lung alveoli where they are exposed to the host immune response (Brennan and Draper, 
1994; Dover et al., 2011). The host immune response either eliminates Mtb or results in a 
latent/dormant state (Bloom and Fine, 1994). The latent state may be reactivated when conditions 
are more favourable to Mtb multiplication (Bloom and Fine, 1994). It is estimated that one third 
of the human populations harbours the dormant state and 8-10 million cases of newly formed 
active. 
  
1.1.2. Methods in TB drug discovery 
New anti-microbial drugs have been identified using either phenotypic or target-led drug discovery 
methods (Payne et al., 2007; Dover et al., 2011; Hughes et al., 2011). Phenotypic drug discovery 
involves screening of small compound libraries for the ability to eliminate target pathogens (Dover 
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et al., 2011; Hughes et al., 2011; Shi et al., 2011). Transposon mutants are used to identify the 
target of compounds that have shown activity via whole genome sequencing (Dunker et al., 2001; 
Warner and Mizrahi, 2014). Phenotypic drug discovery successfully identified the compounds 
bedaquiline and delamanid (Gomez and McKinney, 2004; Payne et al., 2007; Dover et al., 2011). 
Nevertheless, this method has limitations such as low probability of occurrence during screening 
periods (Payne et al., 2007). 
Target-led drug discovery involves a series of methods to identify a “target” molecule essential for  
survival and growth of a pathogen (Dunker et al., 2001). Following the identification of the target, 
high throughput screening methods are used to identify candidate inhibitors (Dunker et al., 2001; 
Warner and Mizrahi, 2014). This method relies on the ability of the candidate molecule to permeate 
the cell and successfully inhibit function to trigger cell death (Warner and Mizrahi, 2014).   
 
1.1.3. Target-led TB drugs and their mode of action 
Whole genome sequencing of Mtb has identified multiple novel protein targets for target-led drug 
discovery and development (Hughes et al., 2011) as well as Mtb strains from clinical isolates 
showing signs of drug resistance (Warner and Mizrahi, 2014). The first-line drug, pyrazinamide 
(PZA), already a key component of the short-course therapy regimen in the 1980’s, was recently 
found to inhibit the ribosomal subunit RpsA (Njire et al.; Shi et al., 2011), essential for ribosome-
sparing and protein translation in trans-translation (Shi et al., 2011). 
DNA polymerases and accessory proteins are suitable drug target candidates to inhibit microbial 
growth (Shi et al., 2011). Inhibiting low-fidelity, error-prone DNA polymerases may constitute 
one way to preventing drug resistance in Mtb. (Dunker et al., 2001; Warner and Mizrahi, 2014). 
http://etd.uwc.ac.za
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Error-prone DNA polymerases such as DnaE2 are crucial for the survivability of the Mtb when 
exposed to DNA damaging agents. Inhibition of DnaE2 without harming the pathogens host can 
be achieved due to the lack of sequence similarities between it and human DNA polymerase. 
 
1.2. DNA replication 
1.2.1. Bacterial DNA replication 
Chromosomal replication involves three major components: a polymerase (Pol III in bacteria), a 
sliding clamp processivity factor (β2 in bacteria) and a clamp loader (DnaX in bacteria). The latter 
two components facilitate the continued interaction of the polymerase with the DNA strand (Baker 
and Bell, 1998; McHenry, 2011c) such that replicative DNA polymerases are only highly 
processive when the sliding clamp and clamp loader are present (Baker and Bell, 1998; McHenry, 
2011a; McHenry, 2011c). 
Prior to elongation, ATP-bound DnaX allows the β2 ring to encircle the ssDNA template and 
chaperones Pol III to the newly bound β2 ring (McHenry, 2011b; McHenry, 2011a; McHenry, 
2011c). DnaX is the core of the replisome, dimerizing Pol III and interacting with replicative 
helicases and primase (McHenry, 2011c; McHenry, 2011b). DnaX increases the rate of replisome 
formation and of Okazaki fragment synthesis during chromosomal replication (Baker and Bell, 
1998; McHenry, 2011a).  
The replisome holoenzyme is stabilized by β2-subunits, the ε-subunit stabilizes the α-subunit 
increasing its affinity for the primer (McHenry, 2011b; McHenry, 2011a; McHenry, 2011c). Once 
assembled, the Pol III holoenzyme replicates the entire chromosome or 5 kb without dissociating 
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(Boshoff et al., 2003; Bruck et al., 2003). The presence of all subunits except β2 increases 
processivity (Baker and Bell, 1998; McHenry, 2011b; McHenry, 2011a; McHenry, 2011c). 
 
1.2.2. DNA polymerase III 
DNA polymerase III (Pol III) is the main replicative polymerase for both RNA primer extension 
and chromosomal replication (McHenry, 2011b; McHenry, 2011a).  Low-GC Gram-positive 
bacteria harbor two Pol III namely homologues PolC and DnaE that subtly differ with respect to 
sub-domain rearrangements but retain the overall polymerase structure (Dervyn et al., 2001; 
McHenry, 2011b; McHenry, 2011c). PolC has Mg2+-dependent proofreading activity not found in 
DnaE polymerase families (Bruck et al., 2003) 
DnaE is closely related to E. coli Pol III in sequence and domain organization (McHenry, 2011a; 
McHenry, 2011c). In Bacillus subtilis, DnaE synthesizes the lagging strand suggesting that PolC 
is a leading strand polymerase (Sanders et al., 2010). 
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Table 1: Three classes of DNA polymerase III's found in E. coli, B. subtilis and P. aeruginosa with accompanying 
accessory factors. (McHenry, 2011b; McHenry, 2011a; McHenry, 2011c) 
Model organism   Proposed Name  Function(s)s Accessory Factors 
E. coli PolC, α-subunit, DnaE Extension of RNA 
primers 
High speed, high fidelity 
chromosomal replication  
β2, DnaXcx 
B. subtilis  PolC 
 
 
DnaE 
High speed, high fidelity 
chromosomal replication 
 
Extension of RNA 
primers 
β2, DnaXcx 
 
 
β2, DnaXcx 
P. aeruginosa DnaE 
 
 
 
 
ImuC/DnaE2 
 
Extension of RNA 
primers  
High speed, high fidelity 
chromosomal replication 
 
High speed, Low-fidelity 
replication  
Induced mutagenesis 
β2, DnaXcx 
 
 
 
 
β2, ImuA, ImuB 
 
In E. coli, PolC has a high elongation rate (~500 nt/s) required for leading-strand replication 
(Blower et al., 1995; McHenry, 2011b; McHenry, 2011a; McHenry, 2011c). DnaE has a much 
slower elongation rate (~25 nt/s), too slow for leading-strand replication (Blower et al., 1995; 
McHenry, 2011b; McHenry, 2011a; McHenry, 2011c).  DnaE cannot functionally replace PolC 
(McHenry, 2011a; McHenry, 2011c) while initiation of lagging-strand replication requires both 
DnaE and a primase (Filee et al., 2002). 
PolC actively discriminates against RNA primers based on the wider diameter of the A-form RNA-
DNA duplex (McHenry, 2011b; McHenry, 2011a; McHenry, 2011c). In DnaE, by contrast, two β-
strands of the thumb domain interact with the minor groove of the RNA-DNA duplex allowing for 
efficient primer extension (McHenry, 2011b; McHenry, 2011c) suggesting that DnaE is part of the 
same replicative pathway (McHenry, 2011b; McHenry, 2011a). 
http://etd.uwc.ac.za
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Figure 1: Model for polymerase switching in low GC Gram-positive bacteria.(McHenry, 2011b) After production of 
theRNA primer, DnaE-β2-clamp loader complex is formed to extend the RNA primer. Once the RNA primer is 
extended, DnaE is switched with PolC in order to complete the DNA replication process. 
In addition to the two replicative DNA polymerase III types, mutagenic Pol III assists with DNA 
repair and induced mutagenesis (McHenry, 2011b; McHenry, 2011a). Numerous bacterial 
genomes shows DnaE homologues not involved in standard replication (McHenry, 2011b; 
McHenry, 2011a; McHenry, 2011c). The Mtb DnaE homologue, DnaE2/ImuC is shown to replace 
the main mutagenic polymerase, PolV, responsible for induced mutagenesis (Le Chatelier et al., 
2004; Warner et al., 2010a; McHenry, 2011b).  
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1.3. Error-prone DNA replication and mutagenesis 
1.3.1. Y-family DNA polymerases  
Replication-blocking lesions pose a threat to cell survival despite the multiple DNA repair 
mechanisms (Collins, 1996). Y-family DNA polymerases have evolved to bypass replication 
blocking lesions with lower fidelity (Friedberg et al., 2001). 
Y-family DNA polymerases are structurally similar to high fidelity, replicative DNA polymerases 
merely adding a single “little finger” (LF) or “polymerase associated domain” (PAD) (Ling et al., 
2001). Y-family DNA polymerases replicate damaged DNA but lack exonucleolytic activity for 
proofreading (Ohmori et al., 2001).  
There are six Y-family DNA polymerase branches: DinB, Rad30A, Rad30B, Rev1, and two 
UmuC. UmuCs are exclusive to prokaryotes with distinct Gram-positive and -negative branches 
(Perry et al., 1985; Ohmori et al., 2001). DinB is widely distributed but absent from S. cerevisiae 
and D. melanogaster (Ohmori et al., 2001; Godoy et al., 2007). RAD30 and Rev1 are eukaryotic 
Y-family polymerases (de Groote et al., 2011), with RAD30(A) or DNA polymerase ƞ 
ubiquitous to eukaryotes, while RAD30B or polɩ is exclusive to higher eukaryotes (Ohmori et 
al., 2001; de Groote et al., 2011) 
 
1.3.2. Y-family DNA polymerase structure 
Structurally, Y-family DNA polymerases consist of a catalytic N-terminal and a DNA-binding and 
-positioning C-terminal domain (Jarosz et al., 2007; Pata, 2010) linked by an unstructured loop 
(Pata, 2010). The N-terminal domain consists a finger, a thumb and a palm subdomain in analogy 
http://etd.uwc.ac.za
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to a human right hand (Trincao et al., 2001; Wei, 2005). Conserved acidic residues responsible for 
DNA repair are located in the palm sub-domain (Trincao et al., 2001). Y-family DNA polymerases 
share the same two-metal-ion coordination for nucleotide placement, as standard replicative 
polymerases (Ling et al., 2001; Pata, 2010). Y-family DNA polymerases have smaller finger and 
thumb sub-domains resulting in an open and solvent-accessible active site (Wei, 2005; Pata, 2010) 
increasing the likelihood of accommodating bulky lesions (Wei, 2005; Wong et al., 2008; Pata, 
2010). 
The C-terminal domain, unique to Y-family DNA polymerases, is referred to as the LF domain in 
prokaryotes and the polymerase associated domain (PAD) in eukaryotes (Lee et al., 2006; Jarosz 
et al., 2007; Pata, 2010). The LF/PAD domain follows the thumb sub-domain in sequence but 
structurally aligns with the finger domain (Wei, 2005; Wong et al., 2008). Despite a lack of 
conserved residues, the LF/PAD domain it structurally highly conserved in all Y-family DNA 
polymerases (Ohmori et al., 2001; Wei, 2005) 
 
1.3.3. SOS response in bacteria 
The SOS response is composed of transcriptional and post-transcriptional regulatory elements to 
detect and repair damaged DNA (Krishna et al., 2007). The SOS response is best understood in E. 
coli - the standard model for bacteria (Krishna et al., 2007). 
The E. coli SOS response is activated by damaged DNA in the form of a single stranded lesion 
(Frank et al., 1996; Belov et al., 2009). RecA/ATP binds the damaged DNA to form a helical 
nucleoprotein filament and the active RecA* (Giese et al., 2008). RecA* is a co-protease assisting 
the autocatalytic cleavage of the repressor LexA (Giese et al., 2008; Belov et al., 2009) allowing 
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the gene umuDC to be expressed producing UmuC and UmuD (Patel et al., 2010). UmuD is 
activated to UmuD’ by RecA* removing the 24 N-terminal amino acids (Frank et al., 1996). 
Depending on the activity of RecA* different proportions of homodimers UmuD2 and UmuD’2 or 
heterodimers UmuD’D will form with distinct affinities for UmuC (Patel et al., 2010; Kuban et 
al., 2012; Belov et al., 2013). The complex UmuD’2C is catalytically active while UmuDD’C and 
UmuD2C are not (Belov et al., 2009). UmuD’2C inhibits non-mutagenic DNA replication 
permitting translesion synthesis (TLS) (Patel et al., 2010). UmuD’2C, RecA*, single-stranded 
binding proteins and subunits of Pol III form a polymerase V mutational complex (Pol V) for TLS 
(Sassanfar and Roberts, 1990; Smith and Walker, 1998; Patel et al., 2010). 
 
1.4. Induced mutagenesis proteins involved in translesion synthesis 
1.4.1. ImuABC cassette 
The imuABC cassette found in all forms of life is critical to DNA replication and mutagenesis 
(Erill et al., 2006; Ippoliti et al., 2012). The original annotations sulA, dinP and dnaE were 
renamed imuA, imuB and imuC to reflect their re-classification as an induced mutagenesis cassette 
(Abella et al., 2007; Ippoliti et al., 2012)  
DnaE2 or ImuC is the main catalytic product of the imuABC cassette (Ippoliti et al., 2012). The 
encoding gene dnaE2 of Mtb is homologous to E. coli dnaE despite not being essential to DNA 
replication (Tippin et al., 2004; Ippoliti et al., 2012). The gene dnaE2 often groups with another 
two genes, imuB and imuA, resulting in its renaming to imuC (Ippoliti et al., 2012).  
The imuB encoded protein ImuB was proposed to be structurally related to Y-family DNA 
polymerases (Ippoliti et al., 2012). However, ImuB lacks the catalytic aspartic acid residues 
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normally required for TLS implying it to be catalytically inactive (Koorits et al., 2007; McHenry, 
2011b). In M. tuberculosis ImuA’, a homologue of ImuA, co-exists with ImuB and DnaE2 (Warner 
et al., 2010b; McHenry, 2011b).  A homologue of imuABC cassette accessory proteins are found 
in D. deserti but lack similarity to known imuB and imuA gene (Ippoliti et al., 2012). This 
homologue was annotated imuY due to its involvement in TLS and its sequence similarity to Y-
family polymerases (Ippoliti et al., 2012). 
The complete imuABC cassette is not found in cyanobacteria or Gram-positive bacteria but can be 
found as single genes regulated by different lexA genes (Ippoliti et al., 2012). Many variation of 
the imuABC cassette occur in different organisms. For an overview see Figure 2. 
 
Figure 2: Configurations of the imuABC cassette in S. meliloti, M. tuberculosis and P. putida. S. meliloti has a full, 
contiguous imuABC cassette regulated by the lexA-SOS system.M. tuberculosis has a split imuABC cassette with a 
variation of imuA annotated imuA’. P. putida, by contrast, has a secondary lexA gene annotated lexA2. 
 
1.4.2. Mycobacterium imuA’BC cassette 
Mtb possesses all components for a functional SOS response mechanism (Ippoliti et al., 2012). In 
addition mycobacterium shows evidence of hyper mutability and adaptive mutation systems 
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(Durbach et al., 1997; Mizrahi and Andersen, 1998). The identification of putative Y-family 
homologues in mycobacterium indicates controlled mutagenic processes being present (Warner et 
al., 2010a; Ippoliti et al., 2012). Nevertheless, several studies failed to demonstrate that Y-family 
homologues are required for DNA damage-response in mycobacterium (Boshoff et al., 2003; Rand 
et al., 2003). 
The Mtb gene Rv3370c that encodes DnaE2/ImuC is upregulated more than 10-fold when cells are 
exposed to mitomycin C (MMC), a potent DNA cross-linking agent (Koorits et al., 2007; Warner 
et al., 2010b). Delta Rv3370c mutants show reduced virulence compared to wild type strains 
(Warner et al., 2010b) and are UV-mutagenesis deficient suggesting that DnaE2/ImuC is directly 
involved in induced mutagenesis similar to TLS (Boshoff et al., 2003; Ippoliti et al., 2012). Mtb 
DnaE2/ImuC has three catalytic aspartate residues similar to those of C-family polymerases. 
Substitution of the catalytic residues eliminates UV-induced mutagenesis and renders the cell 
hypersensitive to MMC treatment - mimicking the dnaE2-deleted mutant and suggesting that 
DnaE2/ImuC is responsible for UV-induced mutagenesis and survival under DNA-damaging 
stress conditions (Boshoff et al., 2003; Koorits et al., 2007; Ippoliti et al., 2012). 
DnaE2/ImuC requires additional proteins for induced mutagenesis (Warner et al., 2010a; 
McHenry, 2011b) demonstrated by elevated levels of DnaE2 not leading to an increased cellular 
mutation rate (Ippoliti et al., 2012). The genes of ImuA’ and ImuB are located approximately 24.7 
kB upstream from dnaE2 on a separate locus (Warner et al., 2010b).  
The expression of the imuA’BC cassette in Mycobacterium is controlled by LexA, as it is in other 
organisms (McHenry, 2011b). Deleting any imuA’BC cassette gene results in comparable 
hypersensitivity to MMC treatment suggesting that all components are part of the same pathway 
(Boshoff et al., 2003; Koorits et al., 2007; Zeng et al., 2011; Ippoliti et al., 2012). 
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1.4.3. Mycobacterium ImuB 
ImuB homologues form a distinct branch within the UmuC subfamily of Y-family DNA 
polymerases and appear to share all structural features of Y-family DNA polymerases including 
the defining C-terminal domain (Koorits et al., 2007; Warner et al., 2010b; Zeng et al., 2011; 
Ippoliti et al., 2012) as well as a β-clamp binding motif in the loop linking the N- and C-terminal 
domains (Warner et al., 2010b). 
Assumed to have a Y-family DNA polymerase structure, sequence analysis and homology 
modelling suggest ImuB lacks catalytic residues rendering it inactive for TLS and DNA repair 
(Warner et al., 2010b) – in common with other ImuB homologues. ImuB would therefore appear 
to be an accessory protein assisting DNAE2 in TLS and DNA repair (Warner et al., 2010b).   
The deletion of the ImuB-encoding gene Rv3394c eliminates UV-mutagenesis comparable to the 
ImuC-deletion phenotype (Warner et al., 2010a). This is similarly true for the protein ImuA’ 
implying that both ImuB and ImuA’ are essential to induced mutagenesis and that ImuA’ is a 
homologue of ImuA (Warner et al., 2010b; Ippoliti et al., 2012). 
ImuB readily interacts with the Mtb β-clamp supporting its accessory role in induced mutagenesis 
(Warner et al., 2010b; Ippoliti et al., 2012). As the only cassette component that interacts with the 
β-clamp ImuB contains a β-binding motif 354QLPLWG359 of the DinB3 family (Warner et al., 
2010b). Replacing these residues eliminates the interaction to the β-clamp (Warner et al., 2010b; 
Ippoliti et al., 2012). The β-binding motif is a highly conserved in ImuB homologues implying it 
may be responsible for polymerase switching (Ippoliti et al., 2012).  
ImuB has been shown to interact with DnaE1/ImuC and ImuA’ – and is, in fact, the only interaction 
partner known for ImuA’ (Warner et al., 2010b). ImuB is correspondingly a candidate for roles 
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such as polymerase switching and β-clamp association (Warner et al., 2010b). Binding of cassette 
components generally involves the ImuB C-terminal domain except for the β-clamp motif (Warner 
et al., 2010b). ImuB lacking the C-terminal domain no longer binds other cassette components 
interacts with the β-clamp (Warner et al., 2010b). 
1.5. Aims of the study 
This study was a collaboration between Professor Wolf-Dieter Schubert of the Structural Biology 
Research Group (SBRG), Department of Biotechnology, University of the Western Cape (UWC) 
and Prof Digby Warner of Institute of Infectious Diseases and Molecular Medicine (IDM), 
University of Cape Town (UCT).  
The aim of the study was to determine the three-dimensional structure of the induced mutagenesis 
protein B (ImuB) from Mycobacterium tuberculosis using X-ray crystallography. The objective 
for achieving the atomic structure is to provide more insight into how induced-mutagenesis in Mtb 
works at the molecular level. ImuB plays a role in the process of DNA repair and induced 
mutagenesis as it is believed to be the center of interaction between the damaged DNA molecule 
and all the components of the mutagenic cassette (Warner et al., 2010b; McHenry, 2011b). 
To achieve the aim it was necessary to 1) generate a three-dimensional homology model of ImuB, 
2) generate a large-scale expression system for ImuB production in E. coli, 3) produce and purify 
ImuB, 4) crystallize and solve the structure of ImuB.   
For expression, the gene of interest was cloned into commercial expression vectors namely pET, 
pGEX, and pMal. To obtain pure ImuB, defined production and purification methods had to be 
established to obtain large amounts of pure for crystallization. Purification strategies were to 
include amylose and immobilized metal-ion affinity as well as size exclusion chromatographies. 
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The hanging-drop vapour diffusion method was used during the entire crystallization experiment 
process. 
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2. Materials and Methods 
2.1. Standard materials  
2.1.1. General chemicals, enzymes, kits, resin and standards 
If not stated otherwise, all chemicals used were purchased in “pro analysis” grade from the 
following companies: Fermentas, Fluka, GE-Healthcare, Invitrogen, Millipore, Promega, Roche, 
New England Biolabs, Finnzymes, BioRad, Novagene and Qiagen. 
Table 2: Table of Enzymes 
Product Supplier 
T4 DNA Ligase Fermentas 
FastDigest BglII restriction enzyme Fermentas 
FastDigest EcoRI restriction enzyme Fermentas 
FastDigest NcoI restriction enzyme Fermentas 
FastDigest XhoI restriction enzyme Fermentas 
FastDigest HindIII restriction enzyme Fermentas 
Factor Xa protease New England Biolabs 
3C Precession protease  UWC 
TEV protease  UWC 
DNAse I Roche 
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Table 3: Table of kits 
Product Supplier  
GeneJET gel extraction kit Fermentas 
GeneJET DNA purification kit Fermentas 
GeneJET plasmid miniprep kit Fermentas 
Phusion high fidelity PCR kit Finnzymes 
 
Table 4: Table of molecular weight standards 
Product Usage Supplier 
PageRuler unstained ladder SDS-PAGE Fermentas 
Precision plus protein all blue standard SDS-PAGE/Western Blot BioRad 
GeneRuler® 1Kb DNA ladder Agarose gel electrophoresis Fermentas 
Unstained protein molecular weight 
marker SDS-PAGE Fermentas 
 
Table 5: Table of resin and reagents 
Products Supplier 
Amylose/agarose resin New England Biolabs 
Bugbuster protein extraction reagent Novagen 
Ni-NTA agarose Qiagen 
SnakeSkin dialysis tubing  Bio-Rad Laboratories  
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2.1.2. Buffers 
All buffers below were prepared to their respective volumes using distilled water purified by the 
Millipore water purification system (Prima) unless stated otherwise. pH was adjusted using a 20 pH 
meter (Crison Instruments, Barcelona, Spain) using 3 M sodium hydroxide (NaOH) and 2 M 
hydrochloric acid (HCl) unless stated otherwise.  
1 M IPTG: 1 M IPTG were prepared in distilled water and sterilized by filtration.  
2 M Tris-HCl: 2 M Tris-HCl pH 7.2 was prepared distilled water. The pH of the buffer was 
adjusted using hydrochloric acid (HCl) and stored at room temperature (RT). 
10% Sodium dodecyl sulphate (10% SDS): 10% SDS was prepared in distilled and stored at RT. 
5 x SDS-running buffer: 5 x SDS-running buffers were prepared using 25 mM Tris pH 8.2, 250 
mM glycine and 0.1% SDS in distilled water. The buffer is diluted to 1:5 with distilled water before 
use. 
5 M NaCl solution: 5 M NaCl stock solution was prepared in distilled water to a final volume of 
1 L and stored at room temperature. 
50 x TAE buffer: 50 x TAE stock was prepare using 242 g/L of tris-base, 57.1 ml/L of glacial 
Acetic acid and 18.6 g/L of EDTA in distilled water. The buffer is diluted to 1:50 with distilled 
water before use. 
500 mM Disodium ethylene-diamine tetra-acetate (EDTA): 500 mM EDTA was in distilled 
water. The pH of the solution was adjusted using NaOH to a final pH of 8.0 and stored at room 
temperature. 
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8 x SDS-Sample buffer: 2.2 mL of 0.5 M Tris-HCl pH 6.8, 4 mL of 87% (v/v) glycerol, 16 mL 
of 10% (w/v) SDS, 200 µL of β-mercaptoethanol and 0.2 g of bromophenol blue. This is then 
stored in 1.5 mL microcentrifuge tubes at room temperature 
Ammonium persulphate (25% APS): 25% (w/v) stocks of ammonium persulphate was prepared 
in distilled water and aliquoted into 1.5mL microcentrifuge tubes for storage at -20°C 
Ampicillin: 100 mg/mL stocks of ampicillin was prepared using distilled water and aliquot into 
1.5 mL microcentrifuge tubes for storage at -20°C 
Column buffer: 20 mM Tris-HCl pH 7.4, 200 mM NaCl, and 1 mM EDTA 
Coomassie staining solution: 30% (v/v) ethanol, 10% (v/v) acetic acid, 0.25% (w/v) coomassie 
Blue R-250   
Destaining solution: 40% (v/v) ethanol, 10% (v/v) acetic acid  
Kanamycin: 25mg/ml stocks of kanamycin was prepared in distilled water and aliquot into 1.5 
mL microcentrifuge tubes for storage at -20°C. 
Luria Bertani medium: 10 g/L tryptone, 5 g/L yeast extract, and 5 g/L NaCl. Media was 
supplemented with either ampicillin or kanamycin depending on the desired expression system. 
Lysis buffer: 10 mM Tris-HCl pH 7.4, 10 mM NaCl, 0.5 mM EDTA, 1% triton X-100 , 100 
µg/mL of DNase and 50 mg/mL lysozyme 
Separating buffer for SDS-PAGE: 1.5 M Tris-HCl pH 8.8 was prepared in distilled water and 
stored at RT. 
Super optimal broth (SOB): 2% (w/v) tryptone, 0.5% (w/v) yeast extract, 10 mM NaCl, 2.5 mM 
KCl and 10 mM MgCl2  
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Super optimal broth with catabolite repressor (SOC): Super optimal broth + 20 mM filtered 
glucose. 
Stacking Buffer for SDS-PAGE: 0.5 M Tris/HCl (pH 6.8) was prepared in distilled water and 
stored at RT. 
2.1.3. Crystallization screens 
The following commercial screens were used to screen for crystallization conditions. 
Table 6: Crystallization screens 
Name  Supplier  
JCSG Core I Suite 
Qiagen 
JCSG Core II Suite Qiagen 
JCSG Core II Suite  Qiagen 
JCSG Core IV Suite Qiagen 
 
2.1.4. Equipment 
Table 7:  List of equipment 
Device Model Company 
Autoclave J.S.D. 400 Hospi 
Water purification system Prima ELGA 
Electrophoresis Mini-PROTEAN® Bio-Rad Laboratories  
Electrophoresis power pack  Power Pac™ basic    Bio-Rad Laboratories 
PCR machine  gene amp® 
PCR  
System 2700  Amersham Biosciences 
Shaking incubator   Multitron II   INFORS 
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Shaker (roller)   Roller mixer SRT6  Stuart® 
Sonication device   Unknown   MSE 
Centrifuges Sorvall® RC6 Thermo Scientific  
 5417C Eppendorf  
 Heraeus fresco17 centrifuge Thermo Scientific 
Nanodrop photometer ND-1000 Spectrophotometer peQLab 
pH meter Basic 20 pH meter Crison Instruments 
Nanolitre Pipette Mosquito 4B TTP LabTech 
Incubator Function line Heraeus Instruments 
Heating block Thermomixer 5436 Eppendorf 
 
2.2. Bioinformatics analysis of ImuB 
2.2.1. Sequence alignment and homology modelling of ImuB 
Homology modelling is the derivation of a three-dimensional model of “target’ protein based on 
experimentally structures of homologous proteins. 
A homology model of ImuB was constructed using the crystal structure of DinB from S. 
solfataricus and the crystal structure of Dpo4 in complex with DNA duplex from S. solfataricus. 
The amino acid sequence of ImuB was aligned to homologous sequences using PROMALS3D 
multiple sequence alignment and structure server 
(http://prodata.swmed.edu/promals3d/promals3d.php). PROMALS3D aligns sequences using 
sequence data and structural similarities based on predicted secondary structure elements. The 
sequence alignment was improved manually using UCSF chimera sequence alignment interface 
(https://www.cgl.ucsf.edu/chimera/).  
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The structural model of ImuB was constructed using the sequence alignment and crystal structures 
of the homologues in Modeller in the UCSF chimera interface. The produced model was refined 
to an energy minimized state using Zhang Labs High-Resolution Protein Structure Refinement 
servers (http://zhanglab.ccmb.med.umich.edu/ModRefiner/). 
2.2.2. Disordered region prediction 
Three distinctive disorder region prediction servers predicted disordered regions within the ImuB 
sequence. The servers used were DISOPRED (http://bioinf.cs.ucl.ac.uk/index.php?id=806), 
DisEMBL (http://dis.embl.de/) and DisProt (http://www.disprot.org/) which predicts disordered 
regions bases on the amino acid composition of the target protein.  
 
 
 
 
 
 
 
 
 
 
http://etd.uwc.ac.za
32 
 
2.3. Cloning strategies to clone Rv3394c into various protein expression 
vectors 
Molecular cloning is a set of molecular techniques used to transfer a DNA fragment into a 
transferable vector, transfer it into a host organism to inter alia produce the desired protein. The 
resulting recombinant DNA molecule is usually in the form of a plasmid vector when replication 
occurs in a bacterial host cell.  
The cloning strategies are briefly summarized in figure 3. Amplification of the Rv3394c gene using 
Phusion HF polymerase, was done with the use of the cycle conditions in table 8. 
Table 8: Polymerase chain reaction (PCR) amplification conditions using Phusion HF DNA polymerase 
PCR step PCR conditions 
Initial denaturing  98°C for 30s 
Three step cycling (25 cycles) 
 
98°C for 7s 
58°C for 15s 
72°C for 45s 
Final elongation 72°C for 7min 
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Figure 3: Cloning strategies used to produce recombinant plasmids for ImuB expression. The Rv3394c gene was amplified from the pMal-c2/Rv3394c construct (A). Rv3394c 
amplicons were a cloned into pET-28a(+) , pGEX-6p2 and pETM-30 for expression in E.coli expression systems.  Tev/Rv3394c was amplified from the produced pETM-30/Rv3394c 
for insertion into the pMal-c2x expression vector to incorporate tev as the protease cut site. 
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2.3.1. Cloning strategy for inserting Rv3394c into pGEX-6P-2 expression 
vector 
Full length Rv3394c was amplified from the pMal-c2X-Rv3394c construct (provided by Dr. Digby 
Warner) using primers  
  
5’-GCTCATAGATCTGTCATGGCCTCCGCTCGC-3’ and  
 
5’-CCTCAGGAACCTTCATTCGTAGCTTCCCTCCAGATACC-3’. 
The amplicon was cloned into the pGEX-6P-2 expression vector using restriction enzyme sites, 
BglII as a BamHI alternative at the 5’ end and EcoRI at the 3’ end. BglII produces the same sticky 
ends as BamHI, which could be annealed to the BamHI sticky ends of the host vector. The Rv3394c 
gene contains a BamHI recognition site at 1462 bp. BglII replaced BamHI to eliminate the 
digestion of the Rv3394c gene. The BamHI recognition site was selected to limit the linker length 
and produce an in-frame fusion protein. The EcoRI recognition site was already found on the host 
plasmid. The 3’ primer was designed to anneal to the 3’ end on the host plasmid, incorporating the 
EcoRI recognition site on the amplicon. The restriction digested amplicon was inserted into the 
expression vector between the BamHI site and the EcoRI site to generate the pGEX-6P-2-Rv3394c 
expression construct, which is designed to produces ImuB as an N-terminally tagged GST fusion 
protein. 
 
 
BglII 
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2.3.2. Cloning strategy for inserting Rv3394c into pET expression vectors and 
tev-Rv3394c into pMal-c2X expression vector 
Full length Rv3394c was amplified from the pMal-c2X-Rv3394c construct using primers  
 
5’ -GTCATACCATGGGAGTGATGGCCTCCGCTCGC- 3’ and  
 
5’ - CCTCAGCTCGAGTTCGTAGCTTCCCTCCAGATACC- 3’.  
The amplicon for each respective construct was cloned into  pETM-30 and pET-28a (+) expression 
vectors using the respective restriction enzymes sites. Generation of the pETM-30-Rv3394c 
expression construct, which produces GST-ImuB-His6.  pET-28a(+)-Rv3394c expression 
construct was designed to produce ImuB as an C-terminally tagged His6.  
Rv3394c and TEV protease recognition region was amplified from the pETM-30-Rv3394c 
construct using primers  
 
5’ -CAACCTCGGGGAATTCGAGAATCTTTATTTTCAGGGC- 3’ and  
 
5’ -CCTCAGAAGCTTTCATTCGTAGCTTCCCTCCAGATACC-3’. 
NcoI 
XhoI 
HindIII 
EcoRI TEV 
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The TEV-Rv3394c amplicon was cloned into the pMal-c2x vector to produce an in frame MBP-
tev-imuB fusion protein. The addition of the tev protease site was done due impotency of factorXa 
protease to cleave MBP-ImuB and due to the ready availability of the in-house produced tev 
protease.   
2.4. Transformation of E. coli 
Transforming an organism like a bacterium involves introducing foreign DNA often as a plasmid 
into the host cell to allow its amplification and transcription. The surface of the cell is changed to 
allow the introduction of the recombinant DNA using external stimuli to increase the cells 
competence to take up foreign DNA.  
2.4.1. Electro-competent cell preparation 
Colonies of E. coli BL21, Rosetta-2 and GeneHogs were inoculated into 10 mL of SOB media in 
a 125 mL Erlenmeyer flask and incubated for 16-18 h at 37°C. 250 mL of pre-warmed SOB media 
in a 1 L flask was inoculated with 2 ml of the overnight pre-culture and allowed to grow to an 
optical density of 0.5- 0.7 at 600 nm. Prior to harvesting, the cells were incubated on ice for 15 
min. Cells were harvested at 2800 rcf for 10 min at 4°C. The supernatant was discarded and the 
cells were allowed to dry on ice to remove access media. The cells were resuspended in 250 mL 
of chilled 10% (v/v) glycerol. The solution was centrifuged at 2800 rcf for 10 min at 4°C and the 
supernatant is discarded. Cells were resuspended in 250 mL of chilled 10% (v/v) glycerol and 
aliquot to a final volume of 50 µL. Samples were flash frozen using liquid nitrogen and stored at 
-80°C until future use. 
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2.4.2. Transformation of E. coli by electroporation 
E. coli GeneHogs, BL21 and Rosetta-2 cells were transformed by electroporation. The electro-
competent cells were incubated with 100ng of plasmid DNA for 10 min on ice. Samples were 
aliquoted into specialized electroporation cuvettes and pulsed with 2.5 kV using an electroporator. 
The electro-transformed samples were allowed to recover in 1 mL of pre-warmed SOC media for 
1 h at 37°C, before being plated on LB agar with the required antibiotic.  
2.5. Protein analysis 
2.5.1. SDS-polyacrylamide gel electrophoresis 
Protein samples were analysed using SDS-PAGE, which separates proteins by their molecular 
weight in an electric field. The proteins are denatured by boiling and by addition of a reducing 
agent. The sodium dodecyl sulphate (SDS) masks the natural charge of proteins and introduces a 
net negative charge proportional to the protein size. The protein samples are concentrated in the 
upper stacking gel which differs from the separating gel in pH, ionic strength, size and pore 
density. 
10 µL of protein samples were mixed with 3 µL of 8 x sample buffer following incubation of the 
mixture for 5 min at 96°C to ensure complete denaturation. The samples were pipetted into the 
stacking gel pockets SDS-PAGE run at 40 mA for 30 min. After the run the gel was stained for 15 
min in staining solution and excess stain removed by incubation of the gel in de-staining solution. 
Gels were air dried in between cellophane sheets in Perspex frames for conservation and storage. 
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12% separating gel:  12 mL acrylamide/bisacrylamide 30% (w/v)/0.8% (w/v) 
    7.6 mL 1.5 M Tris pH 8.8 
    300 µL 10% (w/v) SDS 
10 mL H2O 
    40 µL TEMED 
    100 µL 25% (w/v) APS 
5% stacking gel:  1.5 mL acrylamide/bisacrylamide 30% (w/v)/0.8% (w/v) 
    2.5 mL 0.5 M Tris pH 6.8 
    5.9 mL ddH2O 
    15 µL TEMED 
    25 µL 25% (w/v) APS 
8x sample buffer:  16 mL 10% SDS 
    4 mL glycerol 
    2.2 mL Tris pH 6.8 
    800 µL -mercaptoethanol 
    1 spatula tip bromophenol blue 
Staining solution:   2.5 g Coomassie Brilliant Blue R-250 
300 mL ethanol 
100 mL acetic acid 
De-staining solution:  400 mL ethanol 
    100 mL acetic acid 
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2.5.2. Concentrating protein solutions 
Samples of MBP-ImuB and GST-ImuB-His6 fusion protein were concentrated by 
ultracentrifugation using Vivaspin-2, -6- and -20 concentrators (Sartorius, Göttingen, Germany) 
with a MW cut-off of 10, 25 and 50 kDa. Samples were concentrated at 1000 rcf until the desired 
concentration was obtained. The protein concentration was determined using a ND-1000 
Spectrophotometer by monitoring the absorbance at 280 nm throughout the concentration process. 
The process was stopped when the desired protein concentration of 25 mg/ml was reached. 
 
2.6. Protein production and cell disruption 
2.6.1. Small-scale protein production 
ImuB was produced on a small scale from each of the cloned constructs in E.coli, to determine 
optimal expression conditions. A maximum volume of 25 mL was used to limit wastage. The 
cells containing the construct of interest were inoculated with 2 mL of pre-culture and allowed 
to grow to a desired OD600nm of 0.4 – 0.6. The incubation temperature were varied between 
15°C - 25°C to alter the rate of protein production. The culture was induced with concentration 
of IPTG (20 µM to 500 µM). The bacterial culture was incubated overnight and samples were 
taken before induction, 2 and 4 h after induction, and overnight. Cells were harvested at 
4000 rcf for 30 min and resuspended in Bugbuster protein extraction reagent. For every OD600 
= 0.1 in 100 mL, 100 µL of Bugbuster protein extraction reagent would be added.  The 
resuspended sample was incubated at room temperature for 30 min to rupture the cells. The 
cell lysate of each sample was centrifuged to separate the soluble fraction from the insoluble 
material. Both soluble and insoluble fractions were analyzed using SDS-PAGE. 
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2.6.2. Soluble MBP-ImuB production  
The pMal-c2X-Rv3394c vector with an ampicillin (Amp) resistance gene, was used to produce N-
terminal MBP-ImuB fusion protein. The pMal-c2X-Rv3394c construct was transformed into E. 
coli BL21 cells. 1 L of plasmid-bearing bacteria was incubated at 37°C and 180 rpm in LB-amp 
broth until the culture reached an OD600nm of 0.4 - 0.6. The incubation temperature was decreased 
to 25°C to reduce the rate of protein production and the culture induced with IPTG to a final 
concentration of 0.5 mM. The bacterial culture was incubated overnight and harvested by 
centrifugation at 4000 rcf for 30 min and resuspended in 30 mL of lysis buffer. The resuspended 
sample was incubated at room temperature for 30 min and ruptured via sonication. Cells were 
exposed to sonication for 20 s and rested for 20 s intervals for up to four cycles. The ruptured cells 
were centrifuged at 16000 rcf for 1 h to separate the insoluble material from the soluble materials, 
which contained the MBP-ImuB fusion protein.  
2.6.3. Insoluble ImuB-His6 production 
The pET-28a(+)-Rv3394c construct bears a kanamycin (Kan) resistance gene and produces a C-
terminal His6-ImuB fusion protein after transformation of E. coli BL21 cells. 1 L of plasmid-
bearing bacteria was incubated at 37°C and 180 rpm in LB-amp broth until the culture reached an 
OD600nm of 0.4 - 0.6. The incubation temperature is then decreased to 30°C and the culture is 
induced with IPTG to a final concentration of 0.1 mM. The bacterial culture was allowed to grow 
overnight and harvested at 4000 rcf for 30 min. Cells were resuspended in 30 mL of lysis buffer 
and incubated at RT for 30 min prior to sonication. The ruptured cells were centrifuged at 16000 
rcf for 1 h to separate the insoluble material from the soluble material. The insoluble material 
contained the insoluble ImuB-His6 fusion protein.    
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2.7. Chromatographic methods 
2.7.1. Immobilized metal affinity chromatography (IMAC) of solubilized 
ImuB-His6  
The pET-28a(+)-Rv3394c produces a C-terminally His6-tagged ImuB fusion protein to assist with 
purification via IMAC. Histidine readily binds to immobilized metal ions through its imidazole 
ring.  
Prior to purification, a 10 µL sample of the resin is taken for SDS-PAGE analysis to ensure that 
the resin does not have bound proteins. The cell lysate containing solublilzed ImuB-His6 fusion 
protein, is allowed to couple with Ni-NTA resin for 1 h at room temperature. 3 mL of Ni+2-NTA 
resin was equilibrated with 5 column volumes (CV) of column buffer prior to coupling of the 
soluble cell lysate. Coupling of the cell lysate to the Ni+2-NTA resin was done at 4°C. After 
coupling, the unbound cell lysate is collected as the flow-through and resin was washed with 3x 
100 mL wash buffer. Wash buffer fraction were collected and tested on SDS-PAGE. 20 µL of 
resin was taken after the wash step for later analysis via SDS PAGE. The fusion protein was eluted 
using column buffers with imidazole concentrations of 10 mM, 20 mM, 50 mM, 80 mMand 100 
mM. ImuB-His6 was eluted at an approximate imidazole concentration of 40 mM. Eluted protein 
samples were collected in fractions of 15 mL each. 20 µL of each sample was set aside for analysis 
by SDS-PAGE. 
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2.7.2. Amylose affinity chromatography of soluble MBP-ImuB fusion protein 
The cell lysate containing soluble MBP-ImuB fusion protein was incubated with the amylose resin 
for 1 h at 4°C temperature. The MBP-tag binds amylose with high affinity. 3 mL of amylose resin 
was equilibrated with 5 CV of column buffer. 20 µL of the resin was collected for later analysis 
via SDS PAGE.  The cell lysate was incubated with the amylose resin on a roller mixer overnight 
at 4°C. After coupling of the MBP-ImuB to the amylose resin, the unbound cell lysate is collected 
as the flow-through. The amylose resin was washed with 3x 100 mL each with wash buffer. The 
wash fractions were collected and analysed on SDS-PAGE. 20 µL of resin are taken after the wash 
step for later analysis via SDS PAGE. The fusion protein was eluted using a gradient concentration 
of maltose between 5 mM and 50 mM. Protein was eluted at an approximate maltose concentration 
of 10 mM. Eluted protein samples were collected in fractions of 15 mL each. 20 µL of each sample 
was collected for analysis on SDS-PAGE. A final resin sample was collected after the elution of 
the protein. This was done to ensure that the resin does not contain any of the fusion protein  
2.7.3. Size exclusion chromatography 
Size exclusion chromatography (SEC) separates protein based on their hydrodynamic volume. The 
column matrix consists of porous agarose beads with irregular pores with a diameter up to 34 µM. 
During SEC, larger molecules are excluded from the pores, which reduces their accessible volume. 
This results in earlier elution times.  Smaller particles, experience larger assessable volumes due 
to their accessibility of the pores on the column matrix.  Smaller particles elute later due to the 
increased retention time in the porous matrix. MBP-ImuB was purified using a gel filtration 
column (Superdex 200 16/60, GE Healthcare, Pittsburgh, USA) and 1x PBS as the running buffer. 
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The protein solutions were collected and pooled, the pooled samples were concentrated to a 
maximum of 15mg/mL prior to crystallization experiments.   
2.8.  Protein refolding 
2.8.1. Washing of insoluble protein 
The insoluble ImuB-His6 protein pellet was purified using three wash steps.  During the first step, 
the insoluble pellet is resuspended in buffer containing 1-2% Triton X-100 to solubilizes and hence 
remove membrane fragments and membrane. Following ultracentrifugation at 16000 rcf, the 
supernatant containing solubilized membrane/membrane proteins were discarded.  
The insoluble pellet was resuspended in a buffer containing 10 mM tris pH 7.4 and 1 M NaCl to 
solubilize negatively charged oligonucleotides such as DNA and RNA. In the final step, the pellet 
was washed with standard buffer containing 10 mM tris pH 8.0, 50 mM NaCl, and 8 M Urea to 
denature and solubilize all remaining protein. At each step, a sample was taken to analyze on SDS-
PAGE.  
2.8.2. Refolding using dialysis 
Dialysis is a method of changing buffer components by allowing selective diffusion through a 
semi-permeable membrane (figure. 4). Here, dialysis was used to potentially allow the refolding 
of a target protein – here ImuB – by gradually removing urea as the denaturation agent. The protein 
within the dialysis tube is dissolved in high concentrations of urea. The tube is successively placed 
in buffers with stepwise lower urea concentrations, allowing for the gradual removal of the 
denaturant. Under ideal conditions, this procedure may allow for the refolding of denatured and 
hence unfolded protein to an energetically minimal “native” state.  
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Figure 4: Principle of dialysis ("Dialysis Figure" by Potcherboy at English Wikipedia. Licensed under CC BY 3.0 via 
Commons - https://commons.wikimedia.org/wiki/File:Dialysis_Figure.png#/media/File:Dialysis_Figure.png). 
During the dialysis process, molecules diffuse through semi-permeable membrane to produce an equilibrium between 
molecules in the buffer and the solution within the dialysis tubing.  
Solubilized target protein was transferred to a Bio-Rad SnakeSkin dialysis tube with a 3500 
MWCO.  The target protein-containing dialysis tube was placed in 2 L of the buffer containing 50 
mM Tris pH 8.0 and 50 mM NaCl contain 6 M urea and allowed to incubate for 4 h at 4°C to allow 
the gradual removal of urea. The buffer was replaced with buffer containing 3 M urea and allowed 
to incubate for another 4 h at 4°C. The final buffer change was done using a buffer containing no 
urea. The sample in the dialysis tubing was analyzed using SDS-PAGE at each interval. 
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2.8.3. IMAC on-column refolding 
The solubilized protein was purified using an IMAC column containing 2 mL of Ni-NTA resin. 
The sample was washed with buffer containing 8 M urea and 5 mM imidazole. A resin sample was 
collected after the wash step for SDS-PAGE analysis.  
The immobilized protein was washed with gradient wash steps, which decreased the urea 
concentration. The slow removal of the protein denaturant should in principle allow parameters 
such as hydrophobicity and bond formation to refold the protein to its native, energy minimalized 
state.  
The refolded protein was eluted form the column with buffer containing 50 mM imidazole and 
0.1% Triton X-100. The eluted soluble protein was analyzed on SDS-PAGE.  
 
2.9. Crystallization of MBP-ImuB 
Crystallization experiments were done using commercial crystallization screens (Qiagen, Hilden, 
Germany) in 96-well sitting drop plates.  400 ηL drops composed of equal amounts of protein- and 
crystallization solution were pipetted using the Mosquito 4B nanolitre pipetting robot (TTP 
LabTech, UK). Plates were incubated at constant temperatures (4°C, 16°C and 20°C). Protein 
concentration varied between 5 mg/mL to 25 mg/mL 
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3. Results 
ImuB has been proposed to serve as an adaptor linking the β-clamp, DnaE2 and ImuA’ in a 
transcription complex essential for translesion synthesis in Mtb (Warner et al., 2010a; McHenry, 
2011b). This role of ImuB has, however, not been demonstrated experimentally.. 
 
3.1. Theoretical parameters of ImuB 
ImuB has a theoretical MW of 56.6 kDa and a theoretical pI of 8.16. According to ProtParam 
(http://web.expasy.org/cgi-bin), a protein analysis tool, the estimated half-life of ImuB in E.coli is 
more than 10 h and its instability index is 44, classifying the protein borderline unstable in vitro – 
as a value below forty generally indicates a stable protein (Guruprasad et al., 1990). Removing the 
C-terminal extended region, which extends from the β-clamp motif of ImuB, would reduce the 
instability index to 37 producing a theoretically stable polypeptide. The research group of Prof. 
Digby Warner (IDM, University of Cape Town) previously generated an expression construct for 
full-length ImuB by cloning the gene Rv3394c into the pMal-c2X plasmid. This successfully 
produces soluble ImuB N-terminally fused to MBP in E. coli. pMal-c2x-Rv3394c was not initially 
used due to the inaccessibility of amylose resin for affinity chromatography. This plasmid was 
used as a template for amplification Rv3394c by PCR.  
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3.2. Bioinformatics analysis of ImuB 
3.2.1. Sequence alignment of ImuB 
Structural homologues of ImuB were identified by a protein basic local alignment search tool on 
the UniProt website (http://www.uniprot.org/blast/). A crucial step in homology modelling is 
sequence alignment of the target protein to the sequence of the homologues protein template (Lee 
et al., 2006). ClustalW2 was used to align the Rv3394c sequence to Y-family polymerase 
sequences of M.smegmatis, P.putida, E.coli, and S. solfataricus (See Fig. 5). Further sequence 
alignments were generated using PROMALS3D bioinformatics tool, which aligns protein 
sequences based on structural and predicted sequence identities (Figure 5). Red rings marks acidic 
active side residues conserved in Y-family DNA polymerases. Domain regions were inferred from 
the crystal structure of Dpo4 from S. solfataricus (Pdb Id: 1JX4) and the LF domain region was 
derived using the crystal structure and sequence of E. coli DinB (polymerase IV) 
(http://www.uniprot.org/uniprot/Q47155). 
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Figure 5: Multiple sequence alignment of ImuB homologues and Y-family DNA polymerases from S. solfataricus.  The 
sequences were aligned using the PROMALS3D multiple sequence alignment server 
(http://prodata.swmed.edu/promals3d/promals3d.php). Consensus secondary structures (ss) are indicated by “h” for 
helices and “e” for β-strands. Consensus amino acids (aa) are indicated with the following symbols:  aromatic 
residues “@”; hydrophobic residues “h”; polar residues “p”; compact residues “t”; bulky residues “b”; small 
residues “s”; positively charged residues “+”; negatively charged residues “-”. The domain structure was annotated 
using the known crystal structure of Dpo4 from S. solfataricus (Pdb Id: 1JX4) ; Palm Domain “red”; Finger domain 
“Blue”; Thumb domain “green”;  and LF domain “purple”. The β-binding motif is show using a purple rectangle 
following the LF domain. 
Rv3394c and its M. smegmatis homologue (MSMEG-1622) have  similarities in sequence to the 
Y-family DNA polymerases DinB of E. coli. Significant differences include a C-terminal 
extension in ImuB beyond the β-clamp binding motif predicted to have few secondary structural 
features (Warner et al., 2010b). In addition, ImuB lacks the acidic catalytic residues required for 
polymerase activity (Indicated by red circulated residues on fig. 5). 
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3.2.2. Disordered region prediction of ImuB 
Disordered region prediction used three servers, which predict disordered regions on ImuB 
sequence. Prediction performed using DISOPRED shows high probability on the C-terminal 
extended region.  
 
 
Figure 6: Disordered profile plot of ImuB (DISOPRED). The red box shows high probability of disordered regions 
on ImuB.  The disordered regions indicated by the red box is located C-terminus of ImuB. 
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A summary showing the disordered regions on ImuB, was compiled using the data obtained from 
DisProt, DisEMBL and DisoPRED servers (Figure 9). Prediction of disordered regions shows that 
the C-terminus has a high probability of have unstructured features. 
 
Figure 7: Summary of disordered region prediction of ImuB using DisProt, DisEMBL, and DISOPRED prediction 
servers. Predicted disordered regions are indicated with coloured rectangles based on the method of disordered 
region prediction used. DisProt (Red), DisEMBL (blue) and DISOPRED (yellow)  
 
 
 
 
N-terminus     C-terminus 
C-terminal extension 
β -clamp 
binding 
motif 
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3.3. Generation of constructs for ImuB production 
 
Figure 8: Agarose electrophoresis gel depicting PCR amplification of ImuB and verification of pETM-30-Rv3394c 
clone via restriction digestion. A: Amplification of full length Rv3394c for insertion into expression vectors (pETM-
30, pET-28a (+) and pGEX-6P-2). Lanes 1&2: Duplicate PCR amplification of ImuB for the insertion into pETM-30 
and pET-28a (+). Lanes 3&4: Duplicate PCR amplification of ImuB for the insertion into pGEX-6P-2. Lanes 5,6 & 
7: Verification of pETM-30/Rv3394 clones with the use of Nco1 and Xho1 double digestion.  
Amplification of Rv3394c by PCR resulted in the generation of a 1586 bp amplicon (figure 10.A.) 
pMal-c2X-Rv3394c was used as template DNA for the amplification of Rv3394c. Constructs were 
generated to enable expression of Rv3394c in E. coli expression systems. Rv3394c was cloned into 
pETM-30, pET-28a (+), pGEX-6P-2 and pMal-c2X. The clones were verified using PCR, 
restriction digestion with one exception (pGEX-6P-2 construct) and sequence analysis. Rv3394c 
was successfully cloned into each expression vector to produce ImuB in E.coli expression strains 
(Table 9).  The sequence was analysed by Inqaba Biotech and Stellenbosch University. The pGEX-
6P-2 was not verified using restriction analyses due to the elimination of BamHI restriction site. 
The elimination of the BamHI site occurred when ImuB was ligated using a “sticky end” produced 
with BglIII. 
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3.4. Protein production 
3.4.1. Small scale expression of ImuB 
Rv3394c expression constructs were transformed into BL21 (DE3), and BL21(DE3) derivatives 
Arctic express and Rosetta expression strains for the production of ImuB as a recombinant protein 
in E. coli. E.coli Rosetta was optimized to use codons for expression of eukaryotic proteins 
whereas E.coli arctic express was optimized to produce protein at lower expression temperatures. 
Each transformed strain was subjected to numerous expression conditions, which varied in IPTG 
concentration, expression times, temperature variation and media composition. The ImuB fusion 
protein was visible as a distinct induced band corresponding to the theoretical size of the fusion 
protein on SDS-PAGE. 
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Figure 9: Small-scale production trail of ImuB. A: Small scale production of ImuB from pETM-30-Rv3394c in 
construct in E. coli BL21 expression strain. B: Small-scale production of ImuB from pMal-c2X-Rv3394c in E. coli 
BL21 expression strain. Induction of ImuB was done with 0.5 mM of IPTG at an optical density of 0.5. Cells were then 
grown overnight at a temperature of 25°C. M: Marker, 1: 2 h soluble fraction, 2: 2 h insoluble fraction, 3: 4 h soluble 
fraction, 4: 4 h insoluble fraction, 5: Overnight soluble fraction, 6: Overnight insoluble fraction. 7: Overnight 
insoluble fraction, 8: Overnight soluble fraction, 9: 4 h insoluble fraction, 10: 4 h soluble fraction. 
Expression of soluble MBP-ImuB fusion protein was achieved using 0.5 mM IPTG (Figure 9). 
Expressed GST-ImuB-His6 (~83 kDa) was only visible in the insoluble fraction during expression 
trials of the pETM-30-Rv3394c expression system. Insoluble protein extract containing GST-
ImuB-His6 was collected via centrifugation at 16000 rcf for purification and refolding 
experiments. MBP-ImuB (~99.1 kDa) is produced as both soluble and insoluble protein. Protein 
production using the pMal-c2X-Rv3394c construct was up-scaled to produce larger amount of the 
soluble fusion protein.   
The pMal-c2X-Rv3394c expression system was the only successful construct to produce soluble 
N-terminal tagged MBP-ImuB. All protein production systemsproduced large quantities of 
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insoluble ImuB with exception to pMal-c2x-Rv3394c (see table 9). Insoluble fusion proteinwas 
later used for refolding experiments. Once soluble protein production was achieved from small 
scale expression trials, protein production experiments were up-scaled to larger quantities. 
Table 9: Summary of protein expression tests from various protein expression systems. 
Constructs Cell type  Fusion Protein  Protein production outcome 
pMal-c2X-Rv3394c BL21  MBP- FactorXa -ImuB Fusion protein produces at a seemingly 
equal rate in both soluble and insoluble 
fraction  
 Rosetta  Fusion protein produces in soluble and 
insoluble fraction but in lesser amounts 
when compared to BL21 cell strain 
 Arctic Express  Protein production was equivalent to that 
of the BL21 strain. 
pETM-30-Rv3394c BL21  GST-TEV-ImuB-His6 Protein produced largely in the insoluble 
fraction 
 Rosetta  Protein produced largely in the insoluble 
fraction  
 Arctic Express  Protein produced in the insoluble fraction 
pET-28a(+)-Rv3394c BL21  ImuB-His6 Protein produces on a very low scale in 
the insoluble fraction 
 Rosetta  No indication of induction in both the 
soluble and insoluble fraction 
 Arctic Express  No indication of induction in both the 
soluble and insoluble fraction 
pGEX-6P-2-Rv3394c BL21  GST-3C Precision 
Protease -ImuB 
Protein produced in the insoluble fraction 
 Rosetta  Protein produced in the insoluble fraction 
 Arctic Express  Protein produced in the insoluble fraction 
pMal-c2X-tev-Rv3394c BL21  MBP-FXa-TEV-ImuB Protein produced in the insoluble fraction 
 Rosetta  Protein produced in the insoluble fraction 
 Arctic Express  Protein produced in the insoluble fraction 
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MBP-ImuB from the pMal-c2x-Rv3394c was produced in E. coli BL21, Rosetta and Arctic 
Express cells with the use of LB and various IPTG concentrations. E. coli BL21 and Arctic Express 
produced the highest yields of soluble protein production during the expression trials phase. E. coli 
BL21 was chosen as the main protein expression system to produce MBP-ImuB due to its ability 
to produce fusion protein rapidly when compared to E.coli Arctic Express. E.coli Arctic Express 
requires low incubation temperature to produce protein on higher yields. Protein expression at low 
incubation temperatures requires more time to receive the same yields of protein as the E.coli 
BL21. Increasing of the linker between the MBP-tag and ImuB with the insertion of a TEV 
protease recognition site resulted in the production of insoluble protein. Introduction of the TEV 
protease recognition site was done due to the inability of Fxa to cleave MBP from the ImuB fusion 
protein. This favors the notion that ImuB solubility may be highly dependent on the availability of 
the MBP-tag. 
 
 
 
 
 
 
 
 
 
http://etd.uwc.ac.za
57 
 
3.5. Protein purification 
3.5.1. Affinity purification of MBP-ImuB 
MBP-ImuB was purified using amylose resin as the affinity matrix. Total soluble protein extract 
from lysed cells and amylose resin was incubated for 2 h of a rolling incubator at 4°C to allow for 
optimal binding of MBP-ImuB to the amylose resin. The fusion protein was washed using a high 
salt buffer to remove most of the impurities prior to elution. MBP-ImuB was eluted with a buffer 
containing maltose in the range of 50-500 mM. Eluted fraction were concentrated prior to 
additional purification steps. 
Figure 10: A: Purification of MBP-ImuB using amylose resin affinity chromotography.  Lane M: Molecular Weight 
Marker, Lane 1: Purified MBP-ImuB. Lane 2: Total soluble fraction, Lane 3: Unbound protein Flow-through, Lane 
4: Resin with bound protein before wash, Lanes 5-7: Wash fractions with wash buffer (20 mM Tris-HCl, 200 mM, 
NaCl, 0.5 mM EDTA pH 8.1), Lane 8: Resin sample before cleavage with Fxa, Lane 9-11: Elution with elution buffer 
(20 mM Tris-HCl, 200 mM, NaCl, 0.5 mM EDTA pH 8.1), lane 12: Resin sample after Elution. B: Purification of 
MBP-ImuB using amylose resin and Maltose. Lane M: Marker, Lane 1: Total soluble Fraction. Lane 2: Unbound 
protein flow through, Lanes 3-5: Wash with wash buffer (20 mM Tris-HCl, 200 mM, NaCl, 0.5 mM EDTA pH 8.1) 
Lane 6: Resin sample before elution, Lanes 7-10: Elution of bound protein with elution buffer (20 mM Tris-HCl, 200 
mM NaCl, 50 mM Maltose, and 0.5 mM EDTA)  Lane 11: Resin sample after protein elution. 
Affinity purification of MBP-ImuB resulted in approximately 50% of eluted protein (As seen in 
Fig. 10.B ). Various challenges occurred during the initial purification process. During the affinity 
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purification experiments, cleavage of the MBP-tag from ImuB with the use of Factor Xa protease 
resulted in immediate precipitation of ImuB. This fortified the assumption that the MBP-tag is 
required to solubilize ImuB. Maltose was used to elute the fusion protein from the amylose resin. 
~ 50% of the fusion protein was eluted using buffer containing maltose in the ranges of 20 – 500 
mM. High concentration of MBP-ImuB fusion was found to be “stuck” on the resin. Elution 
attempts with high concentrations of salt and maltose was done but resulted in protein 
precipitation.   
 
3.5.2. MBP-ImuB purification by size-exclusion chromatography 
Size-exclusion chromatography (SEC) was used to separate MBP-ImuB from unknown impurities. 
Protein fractions for the SEC were analyzed using SDS-PAGE to confirm purity of the sample 
fraction. 
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Figure 11: Chromatogram of MBP-ImuB SEC. A: SDS-PAGE image of the eluted peaks. Coloured arrow corresponds 
to peak eluted on Chromatogram. B: Pooled and concentrated elution fractions from SEC purification.   
Two peaks (indicated by yellow and orange bar lines in fig. 11) contained a protein the size of 
MBP-ImuB (figure 11). The eluted protein was ~100 kDa, which is the theoretical size of the 
fusion protein. Each of the peaks were colour-coordinated with the indicated bands on the SDS-
PAGE. SEC chromatograms shows a prevalent peak eluting between 80 – 100 mL with the 
addition of a second overlapping peak between 100 – 120 mL of elution buffer. This pattern has 
occurred often when purifying ImuB using SEC purification. This occurrence gives rise to the 
assumption that MBP-ImuB may exist in two states. In this study, these states will be referred to 
as the dimeric state (orange) and oligomeric state (yellow). These states were pooled and 
concentrated separately for crystallization experiments. 
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3.6. Refolding of ImuB-His6  
ImuB-His6 was purified from insoluble lysate produced using the pET-28a (+)/Rv3394c 
expression vector. The insoluble fraction was washed and solubilized using 8 M Urea.  Coupling 
of the insoluble fraction with Ni-NTA resin removed unwanted protein impurities prior to 
undergoing protein refolding. Elution of the insoluble fusion protein for the dialysis refolding 
experiment was done using an elution buffer containing imidazole (500 mM) and NaCL (200 mM). 
A random variety of Tween 80 and Triton-X100 concentrations were used to assist with the 
refolding of the fusion protein. The adjustment of temperature (4°C, 16°C and 20°C) and buffer 
composition was explored to retrieve possible refolding conditions. Refolding of ImuB-His6 was 
inconclusive using both on-column refolding and dialysis. On-column refolding often resulted in 
precipitated protein, which could not be eluted from the Ni-NTA column. Refolding via dialysis 
often resulted in rapid precipitation within the Bio-Rad SnakeSkin dialysis tubing. No trace of 
fusion protein was found within the soluble fractions for each of the conducted experiments. 
3.7. Crystallization 
MBP-ImuB fusion protein was the only soluble candidate that was used for crystallization 
experiments. Purified MBP-ImuB fractions obtained from size exclusion chromatography were 
pooled, concentrated to 25 mg/mL and stored at 4 ˚C waiting crystallization setup. Distinctive 
crystallization conditions using the JCSG Core Suites were tested with different protein 
concentrations (5-25 mg/mL). Variety of temperatures were exploited for each of the 
crystallization experiment (4°C, 16°C and 20°C). Most of the crystallization conditioned prepared 
resulted in no plausible crystal “hits”. Precipitation of the fusion protein and phase separation were 
common occurrences during crystallization experiments of MBP-ImuB. Protein precipitation 
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generally occurred within a week of crystallization preparation but could take up to two weeks at 
4°C. Precipitant was collected using centrifugation and tested using SDS-PAGE after wash steps 
with salt free buffer. The precipitant was confirmed to be MBP-ImuB. No useable protein crystals 
“hits” were observed during the crystallization protocol. 
3.8. Homology modelling of ImuB using Y-family DNA polymerase crystal 
structures 
Detailed structural data on biological macromolecules still require experimentally verifiable data 
as obtained by x-ray crystallography, nuclear magnetic resonance spectroscopy and electron 
microscopy. However, in the absence of such data, homology modelling can provide useful 
information about a target protein based on features it shares with related proteins and may indicate 
the basic function of the target protein. 
A homology model of ImuB was constructed using the protein modelling software “Modeller”. 
The ImuB model was based on the crystal structures of Dpo4 (PDB id: 1JX4) and DinB (PDB id: 
4IR1) from S. solfataricus and E. coli, respectively. The Zhanglab ModRefiner algorithm was 
used to refine the homology model, which encompasses residues 1-360 only as the homologues 
lack an equivalent C-terminal region.  
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Figure 12: Comparison of the ImuB homology model with the crystal structure of Dpo4 (PDB id: 1JX4) from S. 
solfataricus. A: Truncated ImuB homology model coloured to protein chain progression from Palm Domain “red”; 
Finger domain “Blue”; Thumb domain “green”;  and LF domain “purple”. B: Crystal structure of DinB from S. 
solfataricus (PDB Id: 1K1S) C: Dpo4 from S. solfataricus in a tertiary complex with DNA duplex (PDB Id: 1JX4)  
The ImuB homology model is structurally similar to the Y-family DNA polymerase DinB and 
Dpo4 from S. solfataricus with minor rearrangement of secondary structural elements. The model 
retains an overall right-hand structure reminiscent of Y-family DNA polymerases. Comparison of 
domain structure of the palm, finger, thumb and LF shows that each domain retains the secondary 
structural features in each domain (See figure 12). The palm domain on the ImuB model is similar 
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to the crystal structures of Dpo4 and DinB. The palm domain retains the β-sheet, which harbours 
the catalytic residues in Y-family DNA polymerase.  
 
Figure 13: Close up view of active sites residues on palm domain. A: Close up view of active site residues on the 
ImuB model. B: Close up view of active site on the crystal structure of Dpo4 from S. solfataricus.  
Active sites comparison of ImuB model and Dpo4 crystal structure shows that the ImuB model 
does not share similar carboxylated active site residues (ASP7, ASP105 and GLU106, Dpo4 
numbering) in its palm domain required for two metal ion coordination, which binds and positions 
incoming nucleotide bases(Fig. 13) (Lee et al., 2006; Lehmann et al., 2007). Instead, the residues 
are replaced by MET13, GLY102 and LEU103, all of which lacks a catalytically active carboxylate 
group. The lack of catalytic residues suggests that ImuB is not required as polymerase but required 
for the positioning of DnaE2 and the DNA lesion. 
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4. Discussion:  
4.1. Rv3394c clone generation 
Rv3394c was amplified using PCR and cloned in expression vectors pMal-c2x, pET-28a(+), 
pETM-30 and pGEX-6p2. Cloning of Rv3394c into pGex-6p2 required the use of BglIII restriction 
enzyme as a BamHI alternative. BglIII produces the same restriction overhangs as BamHI, which 
allows for ligation using the BamHI cloning site on pGEX-6p2. The use of BglIII eliminated the 
cleavage of the BamHI site at 1462bp of the Rv3394c gene. 
 
Figure 14: Comparison of BglIII and BamHI cleavage recognition sites and ligation result of BglIII and BamHI 
overhangs. 
Ligation of BgIII and BamHI overhangs produces a non-palindromic site, which could not be 
cleaved using any known restriction enzyme (Figure 14). The cloning of pGEX-6p2-Rv3394c 
could only be verified using sequencing and PCR. Cloning of Rv3394c into pETM-30 and pET-
28a(+) could be achieved using the same Rv3394c amplicon as pET-30 and pET-28(+) has similar 
multiple cloning sites. All cloned constructs were successfully verified using restriction digestion 
with exception to the pGEX-6p2-Rv3394c construct. 
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4.2. Production and purification of MBP-ImuB 
Production of recombinant ImuB in E. coli turned out to be a challenging process as many of the 
constructs produced, resulted in the fusion protein aggregates and insoluble fusion protein. During 
protein expression experiments, most rewarding result was produced from the pMal-c2X-Rv3394c 
expression construct, which produced soluble ImuB in E. coli as an N-terminal MBP fusion 
protein. This result was previously achieved by Dr. Digby Warner’s research group but was not 
explored immediately due to the lack of purification material and factorXa to cleave ImuB from 
MBP affinity tag. As generally seen during expression experiments, the MBP-ImuB fusion protein 
was predominantly produced as insoluble protein with a small amount of soluble protein, which 
was purified for further analysis. Generally, Mtb proteins are difficult to produce solubly in E. coli 
due to the high GC content of their genes, bias codon usage between Mtb and E. coli, protein size, 
hydrophobicity, acidity and the lack of essential chaperones (Lakey et al., 2000).  
pMal-c2X-Rv3394c was used to produce MBP-ImuB on a large scale for processing and 
crystallization. Amylose resin affinity chromatography was the first step to purify MBP-ImuB 
from the soluble E. coli cell lysate. MBP-ImuB was eluted from the resin using maltose, although 
~50 % of the fusion protein remained bound to the resin. Cleavage of the MBP-tag from ImuB 
using FactorXa restriction enzyme always resulted in precipitation implying that the solubility of 
ImuB was directly linked to the presence of the MBP tag. MBP is reported to increase the solubility 
of a fusion protein when compared to other fusion tags (Smyth et al., 2003).  Following initial 
purification step, MBP-ImuB was purified using SEC resulting in overlapping peaks containing 
protein corresponding to the theoretical size of MBP-ImuB when analysed using SDS-PAGE. 
These peaks could be observed as MBP-ImuB exhibiting two protein states within solution. ImuB 
is known to have the ability to self-adhere (Warner et al., 2010b). Fractions under each peak were 
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pooled, and concentrated separately prior to crystallography experiments. Substantial amounts of 
protein, especially the assumed “dimeric” state, precipitated upon concentration. Constantly 
occurring protein precipitation could be due to the instability created by the assumed disordered 
C-terminal region. Proteins with disordered regions are known to aggregate in vitro, making it a 
daunting task to purify the subject for downstream processes (Dunker et al., 2001; Dobson, 2004; 
Cromwell et al., 2006).  
4.3. Crystallization of MBP-ImuB: 
Sitting-drop vapor diffusion crystallization of MBP-ImuB was unsuccessful as no protein crystal 
formation was observed during the screening process using commercial screening kits (JCSG 
crystallization suites).  MBP-ImuB rapidly precipitated in most screen conditions. A common 
occurrence throughout the study was the precipitation of MBP-ImuB during concentration 
processes. Precipitation of ImuB could primarily be due to hydrophobic aggregation, which subtly 
disrupts the folded structure exposing more of the hydrophobic interior to the solution, which is 
common when working with proteins containing disordered regions such as ImuB. Crystal growth 
could be hindered by conformational heterogeneity between ImuB and the fusion protein. ImuB is 
predicted to have a highly disordered C-terminal extension, which could hinder crystal growth by 
decreasing homogeneity of the fusion protein molecule in solution. Flexibility on both C-terminal 
and N-terminal regions could be the major factor for the lack of crystal formation and nucleation.   
 
4.4. Homology modelling of ImuB: 
A homology model of ImuB was produced due to the inability to produce an atomic structure 
experimentally.  
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Homology modelling and sequence alignment shows that ImuB consists of three sections; 1) an 
N-terminal regions, which harbours three polymerase-like domains (palm, finger and thumb 
domain); 2) a C-terminal region, which consists solely of the Y-family polymerase-like LF 
domain; 3) and the disordered C-terminal extension, which extends from the β-clamp binding 
motif. Disordered region prediction and lack of structured homologues predicts that the C-terminal 
extension contains high probability of disordered regions. The C-terminal extension is excluded 
from the model due to the lack of homologues with experimentally determined structural 
information.  
 
4.5. Structural similarity between ImuB and Y-family DNA polymerase 
ImuB is structurally similar to Y-family DNA polymerases such as Dpo4 from E.coli by retaining 
domain structures such as the palm, LF, finger and thumb domains (Ohmori et al., 2001; Ippoliti 
et al., 2012). These domains are positioned in a right-hand-like structure, which favours interaction 
with the DNA duplex. This right-hand-like structure is a well-known feature of polymerases but 
the C-terminal LF domain is unique to Y-family DNA polymerases.  
ImuB is predicted to uniquely possess a disordered C-terminal extension as a feature of ImuB and 
ImuB homologues (Aravind et al., 2013). ImuB furthermore lacks the catalytic residues on the β-
sheet of the palm domain (Asp 7, Asp 105, and Glu 106), disqualifying it as a functional Y-family 
DNA polymerase (Figure 13) (Rechkoblit et al., 2006). Sequence alignment with ImuB and DinB 
from E. coli and S. solfataricus, indicated that ImuB possesses the conserved residues (C66 and 
P67) mainly responsible for the formation of the RecA/UmuD complex during the SOS response 
(figure 5) (Cafarelli et al., 2014). The presence of C66 and P67, classifies ImuB as a member of 
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the DinB3-type Y-family polymerase although ImuB itself does not perform any polymerase 
activity (Cafarelli et al., 2014). Previously ImuB was classified as a member of DinB3-type Y-
family polymerase due to the presence of the β-clamp binding domains (354QLPLWG359) (Bunting 
et al., 2003; Cafarelli et al., 2014). 
 
4.6. ImuB C-terminal extension Vs intrinsic disordered proteins 
Highly disordered regions such as ImuB’s C-terminal extension, are featured domains of intrinsic 
disordered proteins (IDP) (Dunker et al., 2001; Dunker et al., 2008; Turoverov et al., 2010). It is 
common for a protein to contain both structured and unstructured regions therefore this type 
present in ImuB is not unique (Structured N-terminal and unstructured C-terminal regions) 
(Dunker et al., 2001; Dunker et al., 2008). There is a wide number of distinctive proteins exhibiting 
the same structural characteristic such as the prokaryotic ubiquitin-like protein (Pup), which has 
been indicated to be involved in the interaction with the mycobacterial proteosomal ATPase (MPa) 
via its disordered C-terminal region (Chen et al., 2009). The Y-family DNA polymerase, UmuD, 
is also known to have features, which have significantly less secondary and tertiary structural 
aspects reminiscent of IDP’s. IDP’s are often found to have specified biological roles within 
regulatory systems, as they are more likely to assume exact structures upon interaction with their 
regulatory binding partners (Godoy et al., 2007; Ollivierre et al., 2013). ImuB and UmuD2 share 
an extended shorter arms structure that is disordered from the unbound globular C-terminal domain 
(Peat et al., 1996; Wang, 2001; Hawver and Beuning, 2013). Previous binding analysis of ImuB 
with its cassette counterparts pin-points the mechanism of binding to occur using the C-terminal 
extension reminiscent of IDP’s. Structural comparison of the modelled structure of ImuB and the 
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crystal structure UmuD suggests that they may be distant homologues because of their very 
apparent C-terminal region, along their designated Y-family DNA polymerase N-terminal 
structure (Ling et al., 2001; Dunker et al., 2008; Ippoliti et al., 2012; Hawver and Beuning, 2013). 
This would propose that ImuB could function as an analog of UmuD with the use of the C-terminal 
extension which would have key involvement in protein-protein interaction with other components 
in the mutasome such as ImuA’ and DnaE2 (Warner et al., 2010a).  
 
4.7. Proposed role of ImuB: 
ImuB interacts with ImuA’, DnaE2 and DNA implying that ImuB functions as an organizing 
scaffold (Ohmori et al., 2001; Jarosz et al., 2007; Lehmann et al., 2007; Choi et al., 2010). ImuB 
is important in enabling DnaE2 to access the replication fork using its β-clamp binding domain 
upstream of the C-terminal extended region (Warner, 2010; Warner et al., 2010b).  
ImuB is able to form self-interact oligomeric states reminiscent of the UmuD (Sassanfar and 
Roberts, 1990; Smith and Walker, 1998; Warner et al., 2010a). Similar to UmuD, ImuB is induced 
on a large scale when in the presence of damaged DNA in Mtb (Warner et al., 2010b). ImuB 
induction in the presence of DNA damage and the ability of ImuB to self-interact would suggest 
that it may have similar functions to that of UmuD in the E. coli SOS response (Belov et al., 2009; 
Warner et al., 2010a; Warner, 2010). 
Put together, assumptions based on structural features using the homology model and disorder 
prediction suggests that 1) ImuB may plays a key role in the regulation of the initial step of the 
SOS DNA repair mechanism, 2) ImuB may act as an adaptor protein that is able to bind both 
DnaE2 and ImuA’ using its C-terminal region, and binds DNA using its N-terminal non-active 
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polymerase domain, 3) ImuB may be required during the process of polymerase switching through 
the interaction with the β-binding Clamp domain.  
 
4.8. Conclusion and future strategies 
The aim of this study was to produce and purify recombinant ImuB for crystallization and structure 
determination. The Rv3394c gene was successfully amplified by PCR and cloned into protein 
production vectors (see table 9). The vectors were transformed into E. coli host strains and 
analyzed for recombinant protein production. Most expression systems produced substantial 
amount of insoluble ImuB with exception to the pMal-c2x-Rv3394c expression construct. The 
fusion protein, produced from the pMal-c2x-Rv3394c expression vector, was successfully purified 
by amylose affinity chromatography and size exclusion chromatography. Upon cleavage of ImuB 
from the fusion tag, the protein unfortunately precipitated almost immediately. The purified fusion 
protein was concentrated and setup for crystallization, but no useful crystal hits were observed. 
The protein in most wells during crystallization experiments either precipitated or produced phase 
separation within the solution. A comparative model of ImuB was built using homologues with 
available crystal structures. The model structures shows that the N-terminus of ImuB may have a 
characteristic Y-family polymerase-like structure, which lacks the active site residues, conserved 
in other Y-family polymerases. The C-terminus was shown to be uncommon among Y-family 
polymerase yet is conserved amongst ImuB homologues (Koorits et al., 2007; Ippoliti et al., 2012). 
Strategies for protein production and refolding experiments do not result in the same degree of 
success for different protein species and consequently the production of soluble, correctly folded 
protein remains a trial by error process (Soto, 2001). It needs to be noted that the proteolytic 
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stability and solubility of a specific protein cannot be confidently predicted in advance (Smyth et 
al., 2003). Despite being able to recover functional protein in vitro after preparative refolding from 
inclusion, the protein optimization for a specific protein species required time-consuming efforts 
with results that being irregular, may not always result in positive process for a convenient 
downstream application such as macromolecule x-ray crystallography and structure determination 
(Soto, 2001; Smyth et al., 2003). Although a straight soluble protein is desirable, limited 
knowledge about the molecular basis of protein aggregation does not permit successful protein 
folding when it does not occur spontaneously. In the course of the experiment, the production and 
purification of ImuB has become quite a daunting task as the full length protein was speculated to 
not be produced as a fully soluble protein. High rate of insolubility could be due to the fact that 
ImuB has an unstructured C-terminal region, reminiscent of intrinsic disordered protein regions. 
Truncation of ImuB could be a possible solution to the insolubility problem. It is also shown that 
the N-terminal region is predicted to adopt a well-defined Y-family-like polymerase three 
dimensional structure, which could allow for soluble protein production, purification and structure 
analysis. Introduction of a binding partner for ImuB during protein production could stabilize the 
C-terminal domains and produce a soluble macromolecule, which could be further processed and 
analyzed. For future purposes, the co-production of ImuB with its binding partners, DnaE2 and 
ImuA’ should be pursued. This may result in stable complex which can be processed further for 
downstream application and crystallization.  
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